Interestingly, a recent study revealed that the p.V168M mutation in ERLIN2 leads to a phenoconversion, manifesting as amyotrophic lateral sclerosis (ALS) in the second generation, pure HSP in the third generation, and complicated form of HSP in the fourth generation [16]. Here, ERLIN2 is linked to hereditary spastic paraplegia.